Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Immenhausen – page 5

56 clinical trials in Immenhausen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Immenhausen at a glance
56
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

56 trials in Immenhausen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Crizotinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol Myers Squibb International Corporation

Bronchiectasis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Oncoc4 Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Technische Universitaet Dresden

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Immenhausen

What the registry says about research in the country

01 Lung Cancer Research

Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) and its various stages, testing innovative therapies and treatment combinations. Research includes studies on metastatic disease and post-surgery treatments.

  • Advanced treatment combinations
  • Immunotherapy approaches
  • Post-surgical therapies

Multiple studies evaluating novel drug combinations with established treatments like pembrolizumab and chemotherapy.

02 Pulmonary Conditions

Research targeting various respiratory conditions, including chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. Studies focus on improving patient outcomes and testing new therapeutic approaches.

  • COPD management
  • Fibrosis treatments
  • Respiratory therapeutics

Investigations into new medications for managing chronic respiratory conditions and preventing disease progression.

03 Advanced Therapeutics

Innovative research exploring targeted therapies and personalized treatment approaches for various lung conditions. Studies include both early-stage and advanced disease management strategies.

  • Novel drug development
  • Combination therapies
  • Treatment optimization

Focus on developing more effective and personalized treatment options for patients with various lung diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.